1

About us

FNM is committed to increase access to high-quality healthcare by developing, producing and marketing affordable pharmaceutical products in Mozambique and also expand to other African markets.

We provide comprehensive and fully integrated contract manufacturing and development solutions to our customers, from early development to high- volume commercial manufacturing and packaging.

Our 5 Point Product Philosophy:

Safety

Integrity

Strength

Purity

Quality

Established in 2013, FNM works with a number of products, government agencies, investors and vendors. Our product portfolio currently has a total of 43 products whose manufacturing is completed through validation.

Our Mission:

Our mission is to ensure that formulations manufactured are consistently produced of quality standards appropriate to their intended use as outlined by the WHO Good Manufacturing Practices to ensure the Safety, Integrity, Strength, Purity and Quality of the products

Our Vision:

To be a leading regional African Pharmaceutical Company and profitable provider of high-quality pharmaceutical products and solutions that creates strategic value for our customers and partners and provides a rewarding workplace for our employees.

Leadership

Mr.Jose Parayanken

Founder and Marketing Director

Mr. José Parayanken is a businessman of Indian origin. He founded Mozambique Holding Group of Companies; the parent company of FNM. Currently, he serves as the Founder and Managing Director of FNM. In his role at FNM, he is responsible for the successful leadership and management of company's business. He supervises and stirs all company's operations, people and ventures in order to maintain and grow business.

Partnerships

The company also holds a strategic partnership with reputed brands like Viatris and Sociedade Moçambicana de Medicamentos, SA (SMM)

Technology Transfer from Viatris for crucial and cutting edge antiretroviral treatments for Mozambique and the region

FNM partnered with SMM to revitalise their manufacturing infrastructure through a joint venture company Infarma to manufacture OSDs and Parentels in Mozambique.